Published in Obesity and Diabetes Week, June 19th, 2006
"The aim of our work was to carry out a randomized clinical trial with a fast-food Mediterranean-type diet rich in platelet activating factor (PAF) antagonist to investigate the effect on type 2 diabetics and healthy human subject's platelet aggregation," scientists in Greece report.
H.C. Karantonis and colleagues working with the National and Kapodistrian University of Athens explained, "We extracted lipids from fast-food Mediterranean-type foodstuffs, and tested them in vitro for their ability to inhibit...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.